Group K Diagnostics, CDC collaborate

Create PDF

June 2019—Group K Diagnostics has signed an agreement with the Centers for Disease Control and Prevention to design and evaluate a prototype reverse transcriptase loop-mediated isothermal amplification assay for the detection of the Zika virus RNA that can be performed by clinical personnel or health care practitioners where real-time RT-PCR instrumentation is not available. The goal of the collaboration is to transform the CDC-developed, test-tube-based RT-LAMP assay for the detection of Zika virus into a noninvasive, rapid detection technology that can be performed in a clinical setting.